Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Change in Account Payables (2016 - 2026)

Summit Therapeutics filings provide 13 years of Change in Account Payables readings, the most recent being $6.8 million for Q1 2026.

  • Quarterly Change in Account Payables rose 1810.67% to $6.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $21.7 million through Mar 2026, up 1731.58% year-over-year, with the annual reading at $15.3 million for FY2025, 659.45% up from the prior year.
  • Change in Account Payables hit $6.8 million in Q1 2026 for Summit Therapeutics, up from -$2.1 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $17.9 million in Q2 2025 and bottomed at -$3.5 million in Q2 2022.
  • Average Change in Account Payables over 5 years is $1.3 million, with a median of $297000.0 recorded in 2023.
  • The largest annual shift saw Change in Account Payables plummeted 1122.56% in 2024 before it soared 1810.67% in 2026.
  • Summit Therapeutics' Change in Account Payables stood at -$2.4 million in 2022, then skyrocketed by 71.63% to -$672000.0 in 2023, then surged by 327.53% to $1.5 million in 2024, then tumbled by 240.29% to -$2.1 million in 2025, then skyrocketed by 417.11% to $6.8 million in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Change in Account Payables are $6.8 million (Q1 2026), -$2.1 million (Q4 2025), and -$839000.0 (Q3 2025).